A premier source for generic injectables
A new source for injectable pharmaceuticals—the supply you need, with the consistency and quality you demand.
About Leucadia Pharmaceuticals
At Leucadia Pharmaceuticals, we are set to be leaders in the generic injectables market. We’re investing heavily, expanding operations and scientific personnel, while also pursuing partnerships and product acquisitions. Our goal is to provide important new generic injectable products to the acute and specialty markets, and to reach communities and conditions that are under-served.
Leucadia Pharmaceuticals was established in 2015 as the commercial arm of Custopharm, Inc., and is associated with Water Street Healthcare Partners.
Sterile injectable generic drug products
Our injectables are manufactured with precision, sterility, and in accordance
with best manufacturing standards—and delivered to our customers.
Dihydroergotamine Mesylate Nasal Spray
Therapeutic Category:
Antimigraine Agent
- AB Rated
- Does Not Contain Natural Rubber Latex
- Bar Coded
- Preservative Free
Icatibant Injection
Therapeutic Category:
Miscellaneous Therapeutic Agents, Complement Inhibitors
- AP Rated
- Does Not Contain Natural Rubber Latex
- Bar Coded
- Preservative Free
Sodium Tetradecyl
Sulfate Injection, 3%
Therapeutic Category:
Sclerosing Agent
- FDA-Approved
- AP Rated
- Does Not Contain Natural Rubber Latex
- Bar Coded
Valrubicin Intravesical
Solution, USP
Therapeutic Category:
Antineoplastic Agent
- AO Rated
- Does Not Contain Natural Rubber Latex
- Bar Coded
- Preservative Free
Dicyclomine HCI
Injection, USP
Therapeutic Category:
Antispasmodic/Anticholinergic
- AP Rated
- Does Not Contain Natural Rubber Latex
- Bar Coded
- Preservative Free
Pentobarbital Sodium
Injection, USP
Therapeutic Category:
Sedative-Hypnotic/Anxiolytic
- AP Rated
- Does Not Contain Natural Rubber Latex
- Bar Coded
- Preservative Free
Fludarabine Phosphate
for Injection, USP
Therapeutic Category:
Antineoplastic Agent
- AP Rated
- Does Not Contain Natural Rubber Latex
- Bar Coded
- Preservative Free
Leadership
We have assembled an executive team with deep experience in the healthcare industry. We’re ready to take Leucadia Pharmaceuticals to the next level.
William (Bill) has more than 28 years of experience in the pharmaceutical industry. Prior to joining Custopharm, Bill was vice president and general manager of Bedford Laboratories, Inc., where he oversaw a portfolio of more than 100 registered generic injectable products. Previously, he was senior director of product development at Amylin Pharmaceuticals Inc., where he managed development activities for proprietary peptide and protein injectable products. Bill also held positions at Novartis, ESI-Lederle, Barr Laboratories, Inc. and Schein Pharmaceutical, Inc. He began his career as an analytical research chemist. Bill received a doctorate degree in analytical chemistry from The Ohio State University and a bachelor’s degree in chemistry from Purdue University.
Kara Eiseman has more than 18 years of experience in the pharmaceutical industry. Before joining Leucadia Pharmaceuticals, Kara was Vice President of National Accounts for WG Critical Care, a generic injectables company. Kara was also Director of Marketing for Bioniche Pharma, which was acquired by Mylan in 2010. Kara also held marketing positions at APP Pharma (now Fresenius Kabi) and Akorn Pharmaceuticals. Kara received her MBA and MS in marketing from Loyola University Chicago, and her BA in economics from Northwestern University.
William Larkins, PhD
Chief Executive Officer
William (Bill) has more than 28 years of experience in the pharmaceutical industry. Prior to joining Custopharm, Bill was vice president and general manager of Bedford Laboratories, Inc., where he oversaw a portfolio of more than 100 registered generic injectable products. Previously, he was senior director of product development at Amylin Pharmaceuticals Inc., where he managed development activities for proprietary peptide and protein injectable products. Bill also held positions at Novartis, ESI-Lederle, Barr Laboratories, Inc. and Schein Pharmaceutical, Inc. He began his career as an analytical research chemist. Bill received a doctorate degree in analytical chemistry from The Ohio State University and a bachelor’s degree in chemistry from Purdue University.
Kara Eiseman
VP Sales & Marketing
Kara Eiseman has more than 18 years of experience in the pharmaceutical industry. Before joining Leucadia Pharmaceuticals, Kara was Vice President of National Accounts for WG Critical Care, a generic injectables company. Kara was also Director of Marketing for Bioniche Pharma, which was acquired by Mylan in 2010. Kara also held marketing positions at APP Pharma (now Fresenius Kabi) and Akorn Pharmaceuticals. Kara received her MBA and MS in marketing from Loyola University Chicago, and her BA in economics from Northwestern University.
Customer Service
If you need assistance, please contact us via phone at 844-538-2231 or email at info@leucadiapharma.com.
Our Medical Information Line is 877-411-9681.